Paper30108045
Loss of CXCR4 in Myeloid Cells Enhances Antitumor Immunity and Reduces Melanoma Growth through NK Cell and FASL Mechanisms.
Yang J and 7 others. Cancer Immunol Res, 2018. Cited by 62 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Loss of CXCR4 in Myeloid Cells Enhances Antitumor Immunity and Reduces Melanoma Growth through NK Cell and FASL Mechanisms. Papers, record 30108045. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/30108045
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cytotoxicity, Immunologic | Major topic |
| Fas Ligand Protein | Major topic |
| Killer Cells, Natural | Major topic |
| Melanoma, Experimental | Major topic |
| Receptors, CXCR4 | Major topic |
| Animals | |
| Bone Marrow Transplantation | |
| Cell Line, Tumor | |
| Interleukin-18 | |
| Macrophages | |
| Mice, Inbred C57BL | |
| Mice, Transgenic | |
| Neutrophils |
Source PubMed
Grants11
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| S10 OD021804 | NIH HHS | United States | S10OD021804 | PubMed | NIH RePORTER |
| I01 BX001444 | BLRD VA | United States | I01BX001444 | PubMed and NIH | NIH RePORTER |
| R01 CA200681 | NCI NIH HHS | United States | R01CA200681 | PubMed and NIH | NIH RePORTER |
| IK6 BX005225 | BLRD VA | United States | IK6BX005225 | PubMed | NIH RePORTER |
| K12 CA090625 | NCI NIH HHS | United States | K12CA090625 | PubMed | NIH RePORTER |
| R01 CA034590 | NCI NIH HHS | United States | R01CA034590 | PubMed and NIH | NIH RePORTER |
| P30 CA068485 | NCI NIH HHS | United States | P30CA068485 | PubMed and NIH | NIH RePORTER |
| R01 HL121139 | NHLBI NIH HHS | United States | R01HL121139 | PubMed | NIH RePORTER |
| R01 CA116021 | NCI NIH HHS | United States | R01CA116021 | PubMed and NIH | NIH RePORTER |
| IK6 BX004595 | BLRD VA | United States | IK6BX004595 | PubMed and NIH | NIH RePORTER |
| I01 BX002301 | BLRD VA | United States | I01BX002301 | PubMed and NIH | NIH RePORTER |
References44
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 24498562 | CSF1R inhibition delays cervical and mammary tumor growth in murine models by attenuating the turnover of tumor-associated macrophages and enhancing infiltration by CD8+ T cells. | Oncoimmunology | 2013 | https://conductscience.org/library/papers/24498562 | PubMed |
| 2 | 17883327 | Chemokines and their receptors: drug targets in immunity and inflammation. | Annu Rev Pharmacol Toxicol | 2008 | https://conductscience.org/library/papers/17883327 | PubMed |
| 3 | 26967289 | The Basis of Oncoimmunology. | Cell | 2016 | https://conductscience.org/library/papers/26967289 | PubMed |
| 4 | 27471643 | Epithelial NF-κB signaling promotes EGFR-driven lung carcinogenesis via macrophage recruitment. | Oncoimmunology | 2016 | https://conductscience.org/library/papers/27471643 | PubMed |
| 5 | 11489989 | A central role for death receptor-mediated apoptosis in the rejection of tumors by NK cells. | J Immunol | 2001 | https://conductscience.org/library/papers/11489989 | PubMed |
| 6 | 25287686 | The intricate role of CXCR4 in cancer. | Adv Cancer Res | 2014 | https://conductscience.org/library/papers/25287686 | PubMed |
| 7 | 12563297 | Interleukin-12 and the regulation of innate resistance and adaptive immunity. | Nat Rev Immunol | 2003 | https://conductscience.org/library/papers/12563297 | PubMed |
| 8 | 9722546 | The alpha-chemokine, stromal cell-derived factor-1alpha, binds to the transmembrane G-protein-coupled CXCR-4 receptor and activates multiple signal transduction pathways. | J Biol Chem | 1998 | https://conductscience.org/library/papers/9722546 | PubMed |
| 9 | 9744279 | Apoptosis of CD8+ T cells is mediated by macrophages through interaction of HIV gp120 with chemokine receptor CXCR4. | Nature | 1998 | https://conductscience.org/library/papers/9744279 | PubMed |
| 10 | 19451693 | Abrogation of TGF-beta signaling enhances chemokine production and correlates with prognosis in human breast cancer. | J Clin Invest | 2009 | https://conductscience.org/library/papers/19451693 | PubMed |
| 11 | 21219185 | Natural innate and adaptive immunity to cancer. | Annu Rev Immunol | 2011 | https://conductscience.org/library/papers/21219185 | PubMed |
| 12 | 12388552 | CXCR4 is a major chemokine receptor on glioma cells and mediates their survival. | J Biol Chem | 2002 | https://conductscience.org/library/papers/12388552 | PubMed |
| 13 | 24056773 | CSF-1R inhibition alters macrophage polarization and blocks glioma progression. | Nat Med | 2013 | https://conductscience.org/library/papers/24056773 | PubMed |
| 14 | 11509635 | A role for IL-18 in neutrophil activation. | J Immunol | 2001 | https://conductscience.org/library/papers/11509635 | PubMed |
| 15 | 22258454 | Melanoma cells inhibit natural killer cell function by modulating the expression of activating receptors and cytolytic activity. | Cancer Res | 2012 | https://conductscience.org/library/papers/22258454 | PubMed |
| 16 | 19088012 | Translating an Antagonist of Chemokine Receptor CXCR4: from bench to bedside. | Clin Cancer Res | 2008 | https://conductscience.org/library/papers/19088012 | PubMed |
| 17 | 28369682 | Characterization and Functional Analysis of Mouse Semi-invariant Natural T Cells. | Curr Protoc Immunol | 2017 | https://conductscience.org/library/papers/28369682 | PubMed |
| 18 | 19794494 | Membrane-bound Fas ligand only is essential for Fas-induced apoptosis. | Nature | 2009 | https://conductscience.org/library/papers/19794494 | PubMed |
| 19 | 19282848 | Braf(V600E) cooperates with Pten loss to induce metastatic melanoma. | Nat Genet | 2009 | https://conductscience.org/library/papers/19282848 | PubMed |
| 20 | 22393124 | Neutrophil depletion impairs natural killer cell maturation, function, and homeostasis. | J Exp Med | 2012 | https://conductscience.org/library/papers/22393124 | PubMed |
Cited by50
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 62 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42521772 | Spatial transcriptomics differences of histopathological growth patterns in colorectal cancer liver metastases. | Br J Cancer | 2026 | https://conductscience.org/library/papers/42521772 | PubMed |
| 42211393 | Inhibition of chemokine CXCL12 modulates the tumor microenvironment in glioblastoma and potentiates immune checkpoint inhibitor efficacy in a tissue-specific manner. | Neurooncol Adv | 2026 | https://conductscience.org/library/papers/42211393 | PubMed |
| 41582133 | Spatiotemporal dynamics of tumor-associated neutrophils: bridging the gap between cancer progression and immunotherapy. | Mol Cancer | 2026 | https://conductscience.org/library/papers/41582133 | PubMed |
| 41088352 | Turning cold tumors into hot tumors to ignite immunotherapy. | Mol Cancer | 2025 | https://conductscience.org/library/papers/41088352 | PubMed |
| 41044427 | The tumour microenvironment in pancreatic cancer - new clinical challenges, but more opportunities. | Nat Rev Clin Oncol | 2025 | https://conductscience.org/library/papers/41044427 | PubMed |
| 40835726 | Single-cell transcriptome analysis identifies MIF as a novel tumor-associated neutrophil marker for pancreatic ductal adenocarcinoma. | NPJ Precis Oncol | 2025 | https://conductscience.org/library/papers/40835726 | PubMed |
| 40656546 | Cancer-Associated Fibroblasts: Heterogeneity, Cancer Pathogenesis, and Therapeutic Targets. | MedComm (2020) | 2025 | https://conductscience.org/library/papers/40656546 | PubMed |
| 40461514 | Therapeutic potential of tumor-associated neutrophils: dual role and phenotypic plasticity. | Signal Transduct Target Ther | 2025 | https://conductscience.org/library/papers/40461514 | PubMed |
| 40251197 | Epithelial cell competition is promoted by signaling from immune cells. | Nat Commun | 2025 | https://conductscience.org/library/papers/40251197 | PubMed |
| 39998754 | Tumor-infiltrating myeloid cells; mechanisms, functional significance, and targeting in cancer therapy. | Cell Oncol (Dordr) | 2025 | https://conductscience.org/library/papers/39998754 | PubMed |
| 39567761 | The diverse roles of neutrophils from protection to pathogenesis. | Nat Immunol | 2024 | https://conductscience.org/library/papers/39567761 | PubMed |
| 39555061 | Neutrophils promote the activation of monocytes via ROS to boost systemic antitumor immunity after cryo-thermal therapy. | Front Immunol | 2024 | https://conductscience.org/library/papers/39555061 | PubMed |
| 39493309 | Xianling Lianxia formula improves the efficacy of trastuzumab by enhancing NK cell-mediated ADCC in HER2-positive BC. | J Pharm Anal | 2024 | https://conductscience.org/library/papers/39493309 | PubMed |
| 39339180 | Harnessing the Power of NK Cell Receptor Engineering as a New Prospect in Cancer Immunotherapy. | Pharmaceutics | 2024 | https://conductscience.org/library/papers/39339180 | PubMed |
| 38622975 | Heterogeneous characterization of neutrophilic cells in head and neck cancers. | Head Neck | 2024 | https://conductscience.org/library/papers/38622975 | PubMed |
| 38008741 | Exploiting innate immunity for cancer immunotherapy. | Mol Cancer | 2023 | https://conductscience.org/library/papers/38008741 | PubMed |
| 37815869 | Maternal CXCR4 deletion results in placental defects and pregnancy loss mediated by immune dysregulation. | JCI Insight | 2023 | https://conductscience.org/library/papers/37815869 | PubMed |
| 37014552 | Increased SPRY1 expression activates NF-κB signaling and promotes pancreatic cancer progression by recruiting neutrophils and macrophages through CXCL12-CXCR4 axis. | Cell Oncol (Dordr) | 2023 | https://conductscience.org/library/papers/37014552 | PubMed |
| 37010645 | Understanding the functional relevance of oral neutrophils, phenotype and properties in OSCC. | Med Oncol | 2023 | https://conductscience.org/library/papers/37010645 | PubMed |
| 36917949 | Activated fibroblasts in cancer: Perspectives and challenges. | Cancer Cell | 2023 | https://conductscience.org/library/papers/36917949 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CXCL12 | 6387 | PubTator's text mining | https://conductscience.org/library/genes/6387 | NCBI Gene |
| CXCR4 | 7852 | PubTator's text mining | https://conductscience.org/library/genes/7852 | NCBI Gene |
| ITGAM | 3684 | PubTator's text mining | https://conductscience.org/library/genes/3684 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/30108045
GET https://conductscience.org/api/papers/v1/30108045/references?page=2